about
Voriconazole-associated cutaneous malignancy: a literature review on photocarcinogenesis in organ transplant recipientsMelanoma Risk and Survival among Organ Transplant Recipients.A Qualitative Comparison of Symptoms and Impact of Varying Stages of Basal Cell Carcinoma.Chronic phototoxicity and aggressive squamous cell carcinoma of the skin in children and adults during treatment with voriconazole.Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin.No evidence for integrated viral DNA in the genome sequence of cutaneous squamous cell carcinoma.High Rhodotorula sequences in skin transcriptome of patients with diffuse systemic sclerosis.Efficacy and safety of vismodegib in advanced basal-cell carcinoma.Self-reported pigmentary phenotypes and race are significant but incomplete predictors of Fitzpatrick skin phototype in an ethnically diverse population.Diminished humoral responses against and reduced gene expression levels of human endogenous retrovirus-K (HERV-K) in psoriasisSingle-nucleotide polymorphisms in pigment genes and nonmelanoma skin cancer predisposition: a systematic review.Catastrophic squamous cell carcinoma in lung transplant patients treated with voriconazole.Transcription restores DNA repair to heterochromatin, determining regional mutation rates in cancer genomes.IMSA: integrated metagenomic sequence analysis for identification of exogenous reads in a host genomic background.Photosensitizing agents and the risk of non-melanoma skin cancer: a population-based case-control study.Prospects for personalized targeted therapies for cutaneous squamous cell carcinoma.Temporal dissection of tumorigenesis in primary cancersLoss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma.The 7th edition AJCC staging system for cutaneous squamous cell carcinoma accurately predicts risk of recurrence for heart and lung transplant recipients.Laser hair removal for genital gender affirming surgeryNovel CARD11 Mutations in Human Cutaneous Squamous Cell Carcinoma Lead to Aberrant NF-κB Regulation.Targeted next-generation sequencing of TP53 in oral tongue carcinoma from non-smokers.Network analysis of psoriasis reveals biological pathways and roles for coding and long non-coding RNAs.Comparing the Quality of Ambulatory Surgical Care for Skin Cancer in a Veterans Affairs Clinic and a Fee-For-Service Practice Using Clinical and Patient-Reported Measures.Antimicrobial Prophylaxis for Full-Face Laser Resurfacing in Transplant Recipients.Factors affecting sunscreen use and sun avoidance in a U.S. national sample of organ transplant recipients.Voriconazole Exposure and Risk of Cutaneous Squamous Cell Carcinoma, Aspergillus Colonization, Invasive Aspergillosis and Death in Lung Transplant Recipients.NOTCH1 mutations occur early during cutaneous squamous cell carcinogenesisαE-catenin inhibits a Src-YAP1 oncogenic module that couples tyrosine kinases and the effector of Hippo signaling pathway.Safety and efficacy of vismodegib in patients with basal cell carcinoma nevus syndrome: pooled analysis of two trials.Why Cockayne syndrome patients do not get cancer despite their DNA repair deficiency.Memory regulatory T cells reside in human skinSafety and efficacy of vismodegib in patients aged ≥65 years with advanced basal cell carcinoma.Role of human papillomavirus in cutaneous squamous cell carcinoma: a meta-analysis.Incidence of and Risk Factors for Skin Cancer in Organ Transplant Recipients in the United States.Pivotal ERIVANCE basal cell carcinoma (BCC) study: 12-month update of efficacy and safety of vismodegib in advanced BCC.Combined dabrafenib and trametinib therapy in metastatic melanoma and organ transplantation: Case report and review of the literature.Merkel cell carcinoma in organ transplant recipients: Case reports and review of the literature.Variants at the OCA2/HERC2 locus affect time to first cutaneous squamous cell carcinoma in solid organ transplant recipients collected using two different study designs.Sources and consequences of oxidative damage from mitochondria and neurotransmitter signaling.
P50
Q27012442-F28501A4-83A2-4ABE-A150-E127229C1776Q27320787-2197A22A-8B89-441C-ABE7-4A1E36DE3DBBQ30665331-D9F09861-26CC-4C75-9ED7-D9C1E6857885Q33626342-155FBCFD-6739-4302-B346-51B43CC5E0B7Q33683488-FBB3251C-7016-473F-891D-BCB4405AF4CDQ33756745-F5B3307B-87BA-4217-9A93-4526FD9E3988Q33916720-AC364A7F-901C-4379-8B77-0A775DEB21D9Q34032213-001188C9-D659-4F81-80B6-2E4CD7B882C1Q34195567-C84629A1-A47F-4BBC-AB88-701CAA98B229Q34240041-25E60B54-F55A-4B08-B77D-33FE12DFC26CQ34443721-317BF931-C9D9-497C-81CD-DABEF077C0B7Q34614479-28EDA0B5-2C43-439C-8F82-66BAB0BA5A83Q34625791-CE55AC3A-CC1B-40EC-B0A9-8C505D12EC9FQ34746011-7E410A1C-9C20-4072-AFCD-A53562084CE1Q34821979-2C0C25F1-170D-4706-8FC2-B850040B9CE4Q35217649-67EEB010-74E4-48D8-862F-D5E103745F6CQ35275682-80FE60A7-A0B6-4D0A-B2A6-246FE8A548A1Q35471421-F76F17CF-30FB-4AB5-81E8-752F67E37D9DQ35936988-C9F6F4BF-5449-4425-9F86-FCFD695A369EQ36051427-9BB44201-AA49-4F53-8071-4E2AF7533762Q36134453-C94A38B9-EF2E-4AE1-9430-A0A224331C40Q36136577-7EC8CDDF-61F4-4B05-8705-3F39D062100DQ36177423-9A6F961A-555C-4A1C-9995-313B994C3DB5Q36264916-90D6A8E1-422B-4060-91D7-5B505CD9CCD4Q36307238-EE9BADF4-F4EE-4E6B-9992-3E597A367F3AQ36463422-76472344-3277-4E1E-8727-4782C33510DBQ36480011-9FAA3C7F-84D1-4677-AA42-010BBA3239CEQ36580224-E9E95780-1194-4854-842C-B71BB63845E7Q36783017-F7AC42E8-D231-46CB-9E6F-F5CF3B877E41Q37224186-03963236-25F1-4340-847F-68A6FAD5DE68Q37247575-0EA9060A-77E3-4DE5-8D1E-C33BB7D7BC48Q37602195-3E133C45-0A25-4887-B8BB-778891F83A91Q37689077-6B8D5DDB-ADE5-4A1E-8F28-4ADAB235B775Q38195964-D59873E7-1AA2-40D4-90C8-F4B60236B9FFQ38403289-9DC3BD48-EC0D-475B-BC81-D12D0D9E4213Q38484886-86A645EA-94FA-45C5-B291-9468033E349AQ38799770-80158FC9-023A-4955-8DC4-D5C4BB4B0284Q38799774-246629DE-C2BB-4380-8F8C-97ADEA650583Q38813096-0F45CB28-D3C6-41C1-8190-6F0A10EE5024Q38867513-94DEBC4F-611D-442D-AC11-11C4F4A1F599
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Sarah T Arron
@ast
Sarah T Arron
@en
Sarah T Arron
@es
Sarah T Arron
@nl
Sarah T Arron
@sl
type
label
Sarah T Arron
@ast
Sarah T Arron
@en
Sarah T Arron
@es
Sarah T Arron
@nl
Sarah T Arron
@sl
prefLabel
Sarah T Arron
@ast
Sarah T Arron
@en
Sarah T Arron
@es
Sarah T Arron
@nl
Sarah T Arron
@sl
P106
P21
P31
P496
0000-0001-5669-0627